The European Investment Bank (EIB) will provide financing of EUR 25 million to the Austrian biotech…
Continue ReadingTag: biotech
SV Health Investors Closes on New Fund Focused on Creating and Growing Companies That Advance Science and Transform Healthcare
BOSTON, MA -- (Marketwired) -- 04/11/17 -- , the venture capital and growth equity firm formerly…
Continue Reading
ProActive Capital Group Sponsors TEDxWallStreet 2013 to Spread “Filling the Void” Ideas on Wall Street
NEW YORK, NY -- (Marketwired) -- 10/28/13 -- ProActive Capital Group (PCG), a leading capital market…
Continue Reading
Can-Fite BioPharma Successfully Concludes $6,000,000 Public Offering With an Over-Subscription of 300%
Company Expects to Apply to List Its U.S. ADRs on the NYSE MKT
Continue Reading
Can-Fite BioPharma-s CF101 Drug Selected as one of the “Top Autoimmune/Anti-Inflammatory Disease Projects to Watch” by Elsevier Business Intelligence
CF101 Is Currently in Phase III Trials for Psoriasis and Phase II for Rheumatoid Arthritis
Continue Reading
Can-Fite BioPharma to Present Its Liver Cancer Drug at the 18th World Congress on Advances in Oncology in Greece
Phase II Trial to Commence Under FDA Orphan Drug Designation
Continue Reading
Can-Fite-s Subsidiary OphthaliX to Present at Ophthalmology Futures European Forum
To Showcase Clinical Data on CF101 for Treatment of Glaucoma
Continue Reading
Can-Fite CEO Pnina Fishman Interviewed on CorporateProfile.com
PETACH TIKVA, ISRAEL -- (Marketwired) -- 09/23/13 -- (TASE: CFBI), (PINKSHEETS: CANFY), a biotechnology company with…
Continue Reading
Can-Fite-s Level II ADRs Commence Trading on the U.S. OTC Markets
PETACH TIKVA, ISRAEL -- (Marketwired) -- 09/12/13 -- (TASE: CFBI), (OTCQB: CANFY), a biotechnology company with…
Continue Reading
Can-Fite to Present at Rodman & Renshaw Global Investment Conference on September 9, 2013
PETACH TIKVA, ISRAEL -- (Marketwired) -- 09/03/13 -- (TASE: CFBI), (PINKSHEETS: CANFY), a biotechnology company with…
Continue Reading